Skip to content

Cigar Legislation and Regulation in Tobacco for the Young (Project CLARITY)

Addiction Potential, Flavoring Content, and Substitutability of Concept Flavored Cigarillos

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07162935
Acronym
CLARITY
Enrollment
300
Registered
2025-09-09
Start date
2026-02-23
Completion date
2030-05-31
Last updated
2026-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cigar Smoking, Tobacco Use

Brief summary

This clinical trial will recruit young adults who currently use cigarillos and examine the smoking behavior and perceptions of different flavored cigarillos, product ingredients/additives impacting these perceptions, and simulated tobacco use outcomes (quitting, switching) in various policy scenarios where different types of flavors are available on the market.

Detailed description

This clinical trial will isolate the unique effects of concept descriptors on increased cigarillo use and appeal among experienced young adult cigarillo users. The study will seek to determine the addiction potential of concept flavored cigarillos by examining associations of cigarillo flavor type (concept, characterizing, tobacco) and cigarillo flavoring additives/ingredients to complementary measures of product appeal: subjective effects (e.g., satisfaction, reward, taste), actual smoking behavior (e.g., number of puffs), and simulated cigarillo purchasing, other tobacco product substitution, or quitting under different flavor ban scenarios via an Experimental Tobacco Marketplace (ETM).

Interventions

OTHERCigarillo brand 1

Participants will be assessed on puffing behavior, subjective effects, and exhaled carbon monoxide when assigned to using one of three cigarillo brands. Additives and ingredients of the cigarillo used will also be assessed

OTHERCigarillo brand 2

Participants will be assessed on puffing behavior, subjective effects, and exhaled carbon monoxide when assigned to using one of three cigarillo brands. Additives and ingredients of the cigarillo used will also be assessed

OTHERCigarillo brand 3

Participants will be assessed on puffing behavior, subjective effects, and exhaled carbon monoxide when assigned to using one of three cigarillo brands. Additives and ingredients of the cigarillo used will also be assessed

Sponsors

University of Oklahoma
Lead SponsorOTHER
National Institute on Drug Abuse (NIDA)
CollaboratorNIH
West Virginia University
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
NONE

Intervention model description

Other

Eligibility

Sex/Gender
ALL
Age
18 Years to 24 Years
Healthy volunteers
Yes

Inclusion criteria

1. Ages 18 to 24 2. Report past 30-day use of a cigarillo 3. Ability to read English at least an 8th grade level 4. No immediate plans to quit using tobacco 5. At least 1 prior experience with a flavored tobacco product 6. U.S. Citizen or permanent resident of the United States.

Exclusion criteria

1. Current use of smoking cessation pharmacotherapy or nicotine replacement therapy; 2. Pregnant, planning to become pregnant, or currently breastfeeding; 3. Past or current clinically significant heart disease or hypertension, or other smoking-related disease that could preclude successful study completion; 4. Inability to abstain from nicotine/tobacco products for at least 12 hours 5. Unwillingness to use the research cigarillos in the lab

Design outcomes

Primary

MeasureTime frameDescription
Puff numberFrom enrollment to the end of the final smoking visit, approximately 2 weeksNumber of cigarillo puffs
Subjective reward from smokingFrom enrollment to the end of the final smoking visit, approximately 2 weeksSelf-reported reward from cigarillo smoking from a questionnaire. This scale has 5 questions with response options ranging from 1 - not at all to 7 - extremely. The score is averaged across the number of items. Higher ratings indicate greater psychological reward

Countries

United States

Contacts

CONTACTProject Manager
heal-lab@ouhsc.edu405-271-7759
PRINCIPAL_INVESTIGATORAmy Cohn, OhD

University of Oklahoma Health Sciences

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 12, 2026